Page last updated: 2024-08-18

cyclohexanol and Adenocarcinoma

cyclohexanol has been researched along with Adenocarcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bouchard, P; Irani, J; Mottet, N; Oba, R; Salomon, L1
Durand, JP; Goldwasser, F1

Trials

1 trial(s) available for cyclohexanol and Adenocarcinoma

ArticleYear
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
    The Lancet. Oncology, 2010, Volume: 11, Issue:2

    Topics: Adenocarcinoma; Androgen Antagonists; Autonomic Agents; Cyclohexanols; Cyproterone Acetate; Double-Blind Method; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Male; Medroxyprogesterone Acetate; Prospective Studies; Prostatic Neoplasms; Treatment Outcome; Venlafaxine Hydrochloride

2010

Other Studies

1 other study(ies) available for cyclohexanol and Adenocarcinoma

ArticleYear
Dramatic recovery of paclitaxel-disabling neurosensory toxicity following treatment with venlafaxine.
    Anti-cancer drugs, 2002, Volume: 13, Issue:7

    Topics: Adenocarcinoma; Aged; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Phytogenic; Cyclohexanols; Female; Humans; Neurotoxicity Syndromes; Ovarian Neoplasms; Paclitaxel; Paresthesia; Sensation Disorders; Venlafaxine Hydrochloride

2002